Sector Gamma AS
Sector Gamma AS reported 40 stocks worth $461M in its 13F filing for Q2 2026, filed Aug 12, 2026. Its largest holdings are BMY (9.1%), MRK (6.0%) and MDT (6.0%). Compared with Q1 2026, the fund opened new positions in TMO, REGN and ASND, added to MDT, ELV and BMRN, trimmed BMY, MRK and PFE and sold out of UNH, GILD and LNTH.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  BMY Bristol Myers Squibb Co | $41.8M | 9.1% | 726K | −102K (−12%) | 8 of 8 | |
| 2 |  MRK Merck & Co Inc | $27.9M | 6.0% | 217K | −43K (−17%) | 5 of 8 | |
| 3 |  MDT Medtronic PLC F | $27.6M | 6.0% | 352K | +72K (+26%) | 8 of 8 | |
| 4 |  PFE Pfizer Inc | $24.2M | 5.3% | 1M | −87K (−8%) | 8 of 8 | |
| 5 |  INCY Incyte Corp | $19.4M | 4.2% | 171K | −30K (−15%) | 8 of 8 | |
| 6 |  ELV Elevance Health Inc | $17.2M | 3.7% | 44K | +537 (+1%) | 8 of 8 | |
| 7 |  BMRN Biomarin Pharmaceutical Inc | $16.9M | 3.7% | 295K | +55K (+23%) | 8 of 8 | |
| 8 |  TMO Thermo Fisher Scientific Inc | $16.8M | 3.6% | 34K | New position | 4 of 8 | |
| 9 |  CVS Cvs Health Corp | $16.1M | 3.5% | 155K | +20K (+15%) | 8 of 8 | |
| 10 |  IQV Iqvia Holdings | $15.1M | 3.3% | 78K | +38K (+94%) | 2 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 UNH Unitedhealth Group Inc | $9.9M | 36K |
 GILD Gilead Sciences Inc | $7.4M | 53K |
 LNTH Lantheus Hldgs Inc | $7.1M | 93K |
 ASND Ascendis Pharma A/s | $4.9M | 21K |
 HUM Humana Inc | $3.3M | 19K |
🔒 Free account: see all 9.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 12, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Sector Gamma AS 13F FAQ
What does Sector Gamma AS own?
Sector Gamma AS reported 40 stocks worth $461M in its 13F filing for Q2 2026, filed Aug 12, 2026. Its largest holdings are BMY (9.1%), MRK (6.0%) and MDT (6.0%). The table above lists every position in the filing (the top 10 without an account).
What did Sector Gamma AS buy and sell in Q2 2026?
Compared with Q1 2026: 7 new positions, 19 added to, 11 trimmed and 9 sold out. New positions include TMO, REGN and ASND. It sold all of UNH, GILD and LNTH.
When will Sector Gamma AS file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Sector Gamma AS's portfolio worth?
The Q2 2026 filing reports $461M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.